Collectively, these data clearly demonstrate that the EphA3 CAR expressed in primary human CD4+ and CD8+ T cells, whereby it can function in an antigen-dependent manner to signal to induce activation, cytokine secretion, and exert cytotoxic effect on target brain tumor cell lines. Here, CD8A is linked to brain neoplasm.